Login:
Share:
Email Facebook Twitter

Ekf Diagnostics Regulatory News (EKF)



Regulatory News for Ekf Diagnostics (EKF)


Share Price: 29.00Bid: 28.00Ask: 30.00Change: 0.00 (0.00%)No Movement on Ekf Diagnostics
Spread: 2.00Spread as %: 7.14%Open: 29.00High: 29.50Low: 28.30Yesterday’s Close: 29.00





Holding(s) in Company

Tue, 3rd Apr 2012 13:47

RNS Number : 7357A
EKF Diagnostics Holdings PLC
03 April 2012
 

?

 




TR:1- NOTIFICATION OF MAJOR INTEREST IN SHARES



1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:
ii

EKF Diagnostics Holdings PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

x

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):


3. Full name of person(s) subject to the
notification obligation:
iii

BlackRock UK Smaller Companies Fund

4. Full name of shareholder(s)
 (if different from 3.):iv


5. Date of the transaction and date on
which the threshold is crossed or
reached:
v

29th March 2012

6. Date on which issuer notified:

2nd April 2012

7. Threshold(s) that is/are crossed or
reached:
vi, vii

Holding has gone above 4%



 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB0031509804

7,839,890

7,839,890

10,331,778

10,331,778

N/A

4.11%

N/A


B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date
xiii

Exercise/
Conversion Period
xiv

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights







C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date xvii

Exercise/
Conversion period
xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 






Nominal

Delta




Total (A+B+C)

Number of voting rights

Percentage of voting rights

10,331,778

4.11%



 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
xxi

 

 


Proxy Voting:

10. Name of the proxy holder:


11. Number of voting rights proxy holder will cease
to hold:


12. Date on which proxy holder will cease to hold
voting rights:




13. Additional information:

BlackRock International Threshold Reporting Team

14. Contact name:

Andrew Manchester

15. Contact telephone number:

020 7743 5773

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUOSURUVASRAR






DateSourceHeadlineCategory
15-May-13 16:34RNSResult of AGMResults and Trading Reports
15-May-13 07:00RNSAGM StatementResults and Trading Reports
13-May-13 07:00RNSFirst PointMan DNA enrichment products launchedCompany Announcement - General
15-Apr-13 13:34RNSPublication of Annual Report & Notice of AGMResults and Trading Reports
18-Mar-13 07:00RNSFinal ResultsResults and Trading Reports
04-Mar-13 07:00RNSEstablishment of EKF Molecular & AcquisitionMergers, Acquisitions and Disposals
18-Jan-13 07:00RNSPre-close Trading UpdateResults and Trading Reports
21-Dec-12 15:53RNSDirectors' Exercise of OptionsCompany Announcement - General
17-Dec-12 07:00RNSHolding(s) in CompanyHolding(s) in Company
27-Nov-12 16:32RNSHolding(s) in CompanyHolding(s) in Company
09-Nov-12 07:00RNSIssue of EquityCompany Announcement - General
24-Sep-12 07:00RNSHalf Yearly ReportResults and Trading Reports
05-Sep-12 07:00RNSTrading UpdateCompany Announcement - General
14-Aug-12 07:00RNSNICE guidance on type 2 diabetesCompany Announcement - General
10-Aug-12 07:00RNSHemoCue settlement agreementCompany Announcement - General
17-Jul-12 07:00RNSLicensing agreement for kidney markersCompany Announcement - General
16-Jul-12 15:05RNSHolding(s) in CompanyHolding(s) in Company
16-Jul-12 07:00RNSQuo-Lab CE marking & Commercial launchCompany Announcement - General
12-Jul-12 13:11RNSHolding(s) in CompanyHolding(s) in Company
28-Jun-12 07:00RNSDirector's Share OptionsDirectors' Dealings
26-Jun-12 10:30RNSHolding(s) in CompanyHolding(s) in Company
23-May-12 13:00RNSResult of AGMResults and Trading Reports
11-May-12 07:00RNSUpdate on Disposal of IBL AGMergers, Acquisitions and Disposals
20-Apr-12 11:18RNSPublication of Annual Report & Notice of AGMCompany Announcement - General
18-Apr-12 16:50RNSHolding(s) in CompanyHolding(s) in Company
05-Apr-12 07:00RNSDirectors' Exercise of OptionsDirectors' Dealings
05-Apr-12 07:00RNSChina Patent GrantCompany Announcement - General
03-Apr-12 13:47RNSHolding(s) in CompanyHolding(s) in Company
27-Mar-12 07:00RNSDisposal of International Brand Licensing AGMergers, Acquisitions and Disposals
26-Mar-12 08:18RNSAdviser Change of NameCompany Announcement - General


Regulatory news is displayed end of day, each day at 19:00.
Sign up for Live Prices





Datafeed and UK data supplied by NETbuilder and Interactive Data. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.